Abiopharma

Dormant shares – creation of dormant shares

Shareholders register, changes and capital status – redemption of BONDS following repurchases of series 12, 13 and 14

Exercice 2026 : un démarrage progressif avec des fondamentaux mieux orientés. Objectifs annuels confirmés, fourchette de croissance organique resserrée.

A gradual start to FY 2026, with fundamentals moving in the right direction. Full-year targets confirmed with organic growth range narrowed.

Other Report or Announcement

Other Report or Announcement

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Rockwell Automation to Demonstrate Cloud‑Connected Factory Design and Industrial Operations with AWS at Hannover Messe 2026 USA - English Deutschland - Deutsch

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

OMRON and Dassault Systèmes Partner to Revolutionize Manufacturing with Virtual and Real Integration

BetterInvesting™ Magazine Update on The Charles Schwab Corp. (NYSE: SCHW) and Dollar General Corp. (NYSE: DG)

General Announcement: Net Asset Value ("NAV") as of 20 April 2026

Toby Neugebauer Incredibly Bullish on Project Matador and Calls for Sale of Company to Maximize Shareholder Value USA - English USA - English

Financial Statements and Related Announcement: Profit Guidance

JPMorganChase Expands Security and Resiliency Initiative Across Europe